fbpx
close read more

Commitment to transparency

A COMMITMENT TO TRANSPARENCY IN PARTNERSHIPS WITH THE MEDICAL COMMUNITY

A good medicinal product results from the successful collaboration of physicians — who express the needs of patients and test the medicines —and pharmaceutical companies that listen. That is why professionals and healthcare companies need to work together to improve patient access to existing and novel therapeutic solutions.

This collaboration has a very large scope. For the Servier Group it could include, for example:

– Defining its future research programs with the expertise of health professionals by better ascertaining patient needs.

– Better understanding the use of a medicinal product in real conditions in order to adjust any pertaining medical information.

Such collaborations are complex and require both communication and transparency. The Group is therefore committed to declaring its connections with health care professionals and organizations, as well as patient organizations, through the European Federation of Industries and Pharmaceutical Associations (EFPIA) Disclosure Code.

Servier informs every health care professional with whom it works  of the collective commitment to the Disclosure Code, as well as local laws and regulations, particularly with regard to their rights.

What is the EFPIA disclosure code?

The EFPIA code of conduct was created in order to better understand the indispensable partnerships between pharmaceutical companies and the medical community. It is a self-regulating approach whereby pharmaceutical companies commit to make public their interactions with health care professionals and organizations, as well as patient organizations. It was first initiated by the industry at a European level and has since been adapted at a national level by tailoring it to the local features and requirements of individual countries.

What are the rules of local transparency?

In many countries, the regulatory authorities have developed publication rules concerning relations between scientific communities and pharmaceutical companies. The terms and conditions for these publications may vary from one country to another. However, the objective remains the same for all: transparency provides invaluable insight into better understanding the vital role of these interactions.

Servier and local disclosures

Clicking on the link below will direct you to Servier’s disclosures made in accordance with the local regulations and provisions of the EFPIA Disclosure Code.

LOCAL DISCLOSURES

More information on the EFPIA Disclosure Code can be found on the European website www.efpia.eu